News

Researchers have predicted post-operative infections in liver transplant patients by analyzing the fecal microbiome, representing a leap forward in understanding the connection between the gut microbiome and health.

Medicinal psilocybin may prove to be an untapped therapeutic resource for a variety of psychiatric conditions identified by researchers at The Florey.

New research has identified key, naturally occurring biochemical components of a novel therapeutic food that is aimed at repairing malnourished children’s underdeveloped gut microbiomes.

As many as 70-80% of women are affected by nausea and vomiting during pregnancy. Researchers from the University of Cambridge have finally uncovered an underlying cause of pregnancy sickness.

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

Many Black Americans who are thought to have a high risk of developing kidney disease possess a protective genetic variant that nullifies the extra risk, a new study from Columbia researchers has found.

A novel therapeutic approach that induces activation of both arms of the immune system is capable of restoring immune surveillance and protecting against ovarian cancer tumors.

Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to target CD19, show a 100 percent complete response (CR) rate at the higher dose levels studied in the trial.

The SURMOUNT-4 phase 3 clinical trial found that anti-obesity drugs may require long-term use to maintain weight loss. Like diabetes or high blood pressure, obesity may need to be treated chronically.

Most diseases are caused by proteins that have spun out of control. Unfortunately, conventional drugs have been able to stop only a fraction of these troublemakers. A new class of drugs known as PROTACs holds great promise in pharmaceutical research.